190 related articles for article (PubMed ID: 2973283)
1. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
Waites KB; Cassell GH; Canupp KC; Fernandes PB
Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Renaudin H; Bébéar C
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
Kenny GE; Hooton TM; Roberts MC; Cartwright FD; Hoyt J
Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
[TBL] [Abstract][Full Text] [Related]
5. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
[TBL] [Abstract][Full Text] [Related]
6. [In vitro sensitivity to antibiotics of genital mycoplasmas isolated in Toulouse. Study of new molecules (macrolides and quinolones)].
Bauriaud R; Séror C; Lareng MB; Lefèvre JC
Pathol Biol (Paris); 1992 May; 40(5):479-82. PubMed ID: 1495830
[TBL] [Abstract][Full Text] [Related]
7. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Rylander M; Hallander HO
Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
Krausse R; Schubert S
Clin Microbiol Infect; 2010 Nov; 16(11):1649-55. PubMed ID: 20047607
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Gorzynski EA; Gutman SI; Allen W
Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Waites KB; Crabb DM; Duffy LB
Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
Rennie KA; Prasad ES; Wenman WM
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.
Waites KB; Crabb DM; Duffy LB
Antimicrob Agents Chemother; 2003 Jan; 47(1):39-42. PubMed ID: 12499166
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]